학술논문
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
Document Type
Article
Author
Trotman, Judith; Joske, David; Prince, H. Miles; Taylor, Kerry; Lewis, Ian D.; Jonak, Constanze; Trautinger, Franz; Bechter, Oliver; Wolter, Pascal; Bron, Dominique; de Lima, Vladmir Claudio C.; Sanches, Jose Antonio, Junior; Klasa, Richard; Bagot, Martine; Beylot-Barry, Marie; Dalle, Stephane; D'Incan, Michel; Dreno, Brigitte; Grange, Florent; Nicolay, Jan; Stadler, Rudolf; Weichenthal, Michael; Wobser, Marion; Assaf, Chalid; Loquai, Carmen; Quaglino, Pietro; Spina, Michele; Zinzani, Pier Luigi; Bosi, Alberto; Fattori, Pier Paolo; Grzanka, Aleksandra; Walewski, Jan; Lopez-Hernandez, Andres; Ortiz-Romero, Pablo L.; Roca, Jose Juan Rifon; Canales, Silvana Novelli; Dummer, Reinhard; Illidge, Timothy; Johnson, Rod; Whittaker, Sean; Morris, Stephen; McKay, Pam; Scarisbrick, Julia; Duvic, Madeleine; Feldman, Tatyana; Akilov, Oleg; Geskin, Larisa; Horwitz, Steve; Kim, Youn H.; Pro, Barbara; Kuzel, Timothy; Lerner, Adam; Eradat, Herbert; Sokol, Lubomir; Fisher, David C.; Hughey, Sarah; Prince, H Miles; Kim, Youn H; Horwitz, Steven M; Sanches, Jose A; Ortiz-Romero, Pablo L; Akilov, Oleg E; Fisher, David; Dréno, Brigitte; Kuzel, Timothy M; Wang, Yinghui; Palanca-Wessels, Maria Corinna; Zagadailov, Erin; Trepicchio, William L; Zhang, Wenwen; Lin, Hui-Min; Liu, Yi; Huebner, Dirk; Little, Meredith
Source
In The Lancet 5-11 August 2017 390(10094):555-566
Subject
Language
ISSN
0140-6736